Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NBTX
NBTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NBTX News
Nanobiotix Receives FDA Approval for Study Protocol Amendment
May 05 2026
NASDAQ.COM
Nanobiotix Announces FDA Acceptance of Protocol Amendment for NANORAY-312 Clinical Trial
May 04 2026
Newsfilter
Nanobiotix Unveils Preclinical Data for Nanoprimer Platform
Apr 20 2026
NASDAQ.COM
Nanobiotix's Nanoprimer Enhances LNP-DNA Delivery for Cancer Therapy
Apr 20 2026
Newsfilter
Nanobiotix Reports Narrowed Net Loss and Cash Runway Guidance
Apr 01 2026
NASDAQ.COM
Nanobiotix Reports FY 2025 Financial Results
Mar 31 2026
seekingalpha
Nanobiotix Presents Lung Cancer Study Data at ELCC 2026
Mar 30 2026
Newsfilter
Nanobiotix to Report Q4 and FY2025 Financial Results
Mar 26 2026
Newsfilter
Nanobiotix Clarifies No Acquisition Intentions Amid Speculation
Mar 25 2026
NASDAQ.COM
Nanobiotix Responds to Acquisition Speculation
Mar 25 2026
Newsfilter
Nanobiotix Shares Surge on Johnson & Johnson Buyout Rumors
Mar 25 2026
seekingalpha
El Pollo Loco Surges After Strong Q4 Earnings Beat Estimates
Mar 13 2026
Benzinga
BETA Technologies Reports Disappointing Q4 Results
Mar 09 2026
Benzinga
Palvella Therapeutics Stock Soars to $114.69 Following Pipeline Developments
Dec 31 2025
NASDAQ.COM
Nanobiotix Reports Voting Rights and Share Capital Data
Dec 17 2025
Globenewswire
Shareholder Voting Rights and Company Capital Structure
Dec 17 2025
Yahoo Finance
Show More News
